Evidence map›Paper›PMID 35091472›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

A case of convergent evolution: Several viral and bacterial pathogens hijack RSK kinases through a common linear motif.

Frédéric Sorgeloos, Michael Peeters, Yohei Hayashi, Fabian Borghese, Nicolas Capelli, Melissa Drappier, Teresa Cesaro, Didier Colau, Vincent Stroobant, Didier Vertommen and 6 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. RiSKs in Computational Modeling of Isoform-Selective RSK Inhibitors.Journal of chemical information and modeling · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Frédéric SorgeloosVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.ORCID 0000-0002-6492-8524
Michael PeetersVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.ORCID 0000-0002-0775-7888
Yohei HayashiVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.
Fabian BorgheseVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.
Nicolas CapelliVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.
Melissa DrappierVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.ORCID 0000-0002-8504-1308
Teresa CesaroVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.
Didier ColauBrussels Branch, Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium.ORCID 0000-0002-0425-066X
Vincent StroobantBrussels Branch, Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium.
Didier VertommenProtein Phosphorylation Unit (PHOS), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.ORCID 0000-0001-7648-8282
Grégory de BodtVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.
Stéphane MesseVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium.
Ignasi FornéMolecular Biology, Biomedical Centre, Faculty of Medicine, Ludwig-Maximilians-Universität München, 82152 Martinsried, Germany.
Felix Mueller-PlanitzMolecular Biology, Biomedical Centre, Faculty of Medicine, Ludwig-Maximilians-Universität München, 82152 Martinsried, Germany.
Jean-François ColletWelbio, B-1200 Brussels, Belgium.ORCID 0000-0001-8069-7036
Thomas MichielsVirology Unit (VIRO), de Duve Institute, Université Catholique de Louvain, B-1200 Brussels, Belgium; thomas.michiels@uclouvain.be.ORCID 0000-0001-9615-8053

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbes have been coevolving with their host for millions of years, exploiting host resources to their own benefit. We show that viral and bacterial pathogens convergently evolved to hijack cellular mitogen-activated protein kinase (MAPK) p90-ribosomal S6-kinases (RSKs). Theiler's virus leader (L) protein binds RSKs and prevents their dephosphorylation, thus maintaining the kinases active. Recruitment of RSKs enables L-protein-mediated inhibition of eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2 or PKR) and stress granule formation. Strikingly, ORF45 protein of Kaposi's sarcoma-associated herpesvirus (KSHV) and YopM protein of

Indexed as

BacteriaBacterial InfectionsBiological EvolutionCell LineGene Expression Regulation, ViralHost Microbial InteractionsHumansImmediate-Early ProteinsMAP Kinase Signaling SystemMitogen-Activated Protein Kinase KinasesRibosomal Protein S6 Kinases, 90-kDaVirus DiseasesVirusesVirus ReplicationImmediate-Early ProteinsMitogen-Activated Protein Kinase KinasesRibosomal Protein S6 Kinases, 90-kDahost–pathogen interactioninnate immunitypicornavirusshort linear motiftype-3 secretion

Identifiers

PMID35091472
PMCPMC8812568

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.